Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy.
about
Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Regulatory T cell frequency, b ...... venous immunoglobulin therapy.
@en
Regulatory T cell frequency, b ...... venous immunoglobulin therapy.
@nl
type
label
Regulatory T cell frequency, b ...... venous immunoglobulin therapy.
@en
Regulatory T cell frequency, b ...... venous immunoglobulin therapy.
@nl
prefLabel
Regulatory T cell frequency, b ...... venous immunoglobulin therapy.
@en
Regulatory T cell frequency, b ...... venous immunoglobulin therapy.
@nl
P2093
P2860
P1476
Regulatory T cell frequency, b ...... venous immunoglobulin therapy.
@en
P2093
Emmanuel Stephen-Victor
Francis Bolgert
Jamma Trinath
Jean-Michel Vallat
Kithiganahalli N Balaji
Laurent Magy
Magalie Rabin
Mohan S Maddur
Mrinmoy Das
Praveen Prakhar
P2860
P2888
P356
10.1186/S12974-017-0818-5
P577
2017-03-20T00:00:00Z
P6179
1084251524